NCT05136755View on ClinicalTrials.gov

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Major Depressive Disorder
Interventions
DRUG

NMDAE

Use of an NMDA enhancer for the treatment of antidepressant nonresponders with MDD

DRUG

Placebo Cap

Use of placebo as a comparator

Trial Locations (1)

Unknown

RECRUITING

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER